New report recommends making pharmacare permanent with annual funding as progress on bilaterals remains stalled
Interim NDP leader Don Davies says the feds must continue negotiating deals with provinces and territories under the pharmacare law passed last year.
Canada’s research strength is world-class—now we need to all pull in the same direction
Our innovation system remains fragmented. Partnerships between universities, industry and government are often too ad hoc, funding cycles are short, and incentives are often misaligned.
Canada could have access to more than 10,000 doctors if licensing were less complicated, House Health Committee hears
The House Health Committee is looking into the links between immigration and health human resources shortages. But Liberal MP Mark Powlowski says the Conservatives’ language on this ‘ticks’ him off as it suggests the problem in health care is a result of too many immigrants, which ‘is clearly wrong.’
CMA leads health lobbying in lead up to budget
MPs have been on the Hill for less than three months this year thanks to prorogation this past winter and the spring election campaign, making lobbying a challenge in 2025.
Stakeholders lament lack of timelines, ‘concrete’ action plans for fixing health care after ministers’ annual meeting
Health Minister Marjorie Michel said something could happen with pan-Canadian licensure for doctors in 2026 but the organization responsible for this work isn’t making any promises.
‘Cutting red tape,’ mental health and primary care on the health docket this fall
Amid the Liberals’ focus on building a stronger economy, Health Minister Marjorie Michel’s office says that faster access to new medicines and supporting researchers are priorities.
Liberals need to get it together on pharmacare
A strong government instills confidence in the country’s people and its businesses. This government’s waffling on pharmacare does none of that.
Canada at risk of collateral damage in U.S. drug pricing war
A proactive and co-ordinated strategy from the government is essential to safeguard both access and affordability to medicines for the long term.
A broken promise, yet again: Why Canada needs national pharmacare now
As an emergency room doctor, I watch seniors decide between groceries and blood pressure pills; I see new immigrants ration insulin. In a country as wealthy and compassionate as Canada claims to be, this is cruel.
Saskatchewan, Newfoundland, Nunavut, and Northwest Territories all open to pharmacare talks, but say they’re not taking place
The Carney government’s commitment to a national program is in question after the Liberals promised to ‘protect’ pharmacare during the 2025 campaign. Health Minister Marjorie Michel’s office says it will honour the four existing deals, but is not promising to negotiate others.
